On 22 September 2006, application was made to list 25,000 ordinary 0.5p shares in Lidco Group plc following the exercise of share options. Admission of new ordinary shares to AIM is expected to become effective at 8 am on 27 September 2006.

Notes to Editors

About LiDCO Group Plc
LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO’s technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery.  The technology was invented in the Department of Applied Physiology based at St Thomas’ Hospital, London.

The Company’s manufacturing facility is in London N1, UK and its products are:

• LiDCOplus and PulseCO monitors: computer-based platforms for displaying and management of a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume;
  
  
• LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner.

Distribution Network:
The Company has now achieved registration of its products in 14 markets in Europe, together with the USA, Brazil and Japan.  It sells direct in the USA and UK, and elsewhere through a worldwide network of specialty critical care distributors